Jing W Hughes1, Jennifer A Wyckoff2, Abby S Hollander3, Colin P Derdeyn4, Janet B McGill5. 1. Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: jing.hughes@wustl.edu. 2. Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA. 3. Division of Pediatric Endocrinology and Metabolism, Washington University School of Medicine, St. Louis, MO, USA. 4. Division of Diagnostic Radiology, Neuroradiology Section, Washington University School of Medicine, St. Louis, MO, USA. 5. Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
CONTEXT: Moyamoya syndrome is an idiopathic brain vasculopathy characterized by stenosis of major intracranial arteries. It often presents in patients with type 1 diabetes or thyroid disease and may have an autoimmune etiology. Moyamoya-related stroke poses a diagnostic challenge as initial symptoms and deficits vary greatly from classic ischemic stroke to encephalopathy, psychiatric, or seizure disorder. CASE DESCRIPTION: We report 4 patients with type 1 diabetes and other autoimmune diseases who developed moyamoya-related stroke at a young age. Despite having long-term diabetes, these patients exhibited no evidence of dyslipidemia or other typical risk factors for atherosclerosis which might contribute to premature stroke. Three of the four patients underwent revascularization surgery while one patient received conservative management. All patients had improved neurologic function after treatment, some with residual deficits. CONCLUSION: We highlight the importance of recognizing moyamoya syndrome in patients with pre-existing autoimmune diseases such as type 1 diabetes, as prompt diagnosis and treatment can have major impact on patient outcome and quality of life.
CONTEXT: Moyamoya syndrome is an idiopathic brain vasculopathy characterized by stenosis of major intracranial arteries. It often presents in patients with type 1 diabetes or thyroid disease and may have an autoimmune etiology. Moyamoya-related stroke poses a diagnostic challenge as initial symptoms and deficits vary greatly from classic ischemic stroke to encephalopathy, psychiatric, or seizure disorder. CASE DESCRIPTION: We report 4 patients with type 1 diabetes and other autoimmune diseases who developed moyamoya-related stroke at a young age. Despite having long-term diabetes, these patients exhibited no evidence of dyslipidemia or other typical risk factors for atherosclerosis which might contribute to premature stroke. Three of the four patients underwent revascularization surgery while one patient received conservative management. All patients had improved neurologic function after treatment, some with residual deficits. CONCLUSION: We highlight the importance of recognizing moyamoya syndrome in patients with pre-existing autoimmune diseases such as type 1 diabetes, as prompt diagnosis and treatment can have major impact on patient outcome and quality of life.
Authors: Regina S Bower; Grant W Mallory; Macaulay Nwojo; Fredric B Meyer; Yogish C Kudva Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391
Authors: Christopher L Hallemeier; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Ralph G Dacey; Colin P Derdeyn Journal: Stroke Date: 2006-04-27 Impact factor: 7.914
Authors: R Michael Scott; Jodi L Smith; Richard L Robertson; Joseph R Madsen; Sulpicio G Soriano; Mark A Rockoff Journal: J Neurosurg Date: 2004-02 Impact factor: 5.115
Authors: Tara K Sigdel; Lorelei D Shoemaker; Rong Chen; Li Li; Atul J Butte; Minnie M Sarwal; Gary K Steinberg Journal: Orphanet J Rare Dis Date: 2013-03-21 Impact factor: 4.123
Authors: Joanne R Festa; Lauren R Schwarz; Neil Pliskin; C Munro Cullum; Laura Lacritz; Fady T Charbel; Dana Mathews; Robert M Starke; E Sander Connolly; Randolph S Marshall; Ronald M Lazar Journal: J Neurol Date: 2009-12-24 Impact factor: 4.849
Authors: Jing W Hughes; Yicheng K Bao; Maamoun Salam; Prajesh Joshi; C Rachel Kilpatrick; Kavita Juneja; David Nieves; Victoria Bouhairie; Olivia J Jordan; Erica C Blustein; Garry S Tobin; Janet B McGill Journal: Diabetes Care Date: 2018-10-25 Impact factor: 19.112